Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA368819
Max Phase: Preclinical
Molecular Formula: C37H52ClN9O13
Molecular Weight: 866.33
Molecule Type: Small molecule
Associated Items:
ID: ALA368819
Max Phase: Preclinical
Molecular Formula: C37H52ClN9O13
Molecular Weight: 866.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N(O)CCC[C@H](NC(=O)[C@H](CCCN(O)C(C)=O)NC(=O)[C@@H](N)CCCN(O)C(C)=O)C(=O)N[C@@H](C(=O)NC1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1
Standard InChI: InChI=1S/C37H52ClN9O13/c1-20(48)44(58)17-7-12-25(39)32(51)40-26(13-8-18-45(59)21(2)49)33(52)41-27(14-9-19-46(60)22(3)50)34(53)42-29(23-10-5-4-6-11-23)35(54)43-30-28-16-15-24(38)31(37(56)57)47(28)36(30)55/h4-6,10-11,25-30,58-60H,7-9,12-19,39H2,1-3H3,(H,40,51)(H,41,52)(H,42,53)(H,43,54)(H,56,57)/t25-,26-,27-,28+,29+,30?/m0/s1
Standard InChI Key: YXTBOLFVQWCWJQ-PKAXTMRISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 866.33 | Molecular Weight (Monoisotopic): 865.3373 | AlogP: -0.78 | #Rotatable Bonds: 22 |
Polar Surface Area: 321.65 | Molecular Species: ACID | HBA: 13 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.20 | CX Basic pKa: 7.58 | CX LogP: -6.29 | CX LogD: -6.54 |
Aromatic Rings: 1 | Heavy Atoms: 60 | QED Weighted: 0.04 | Np Likeness Score: 0.15 |
1. Dolence EK, Minnick AA, Lin CE, Miller MJ, Payne SM.. (1991) Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxy-L-ornithine-derived siderophore-beta-lactam conjugates: iron-transport-mediated drug delivery., 34 (3): [PMID:1825850] [10.1021/jm00107a014] |
Source(1):